nonalcoholic fatty liver disease	is a	liver disease
obesity	is a risk factor for	nonalcoholic fatty liver disease
insulin resistance	is a risk factor for	nonalcoholic fatty liver disease
nonalcoholic fatty liver disease	may progress to	nonalcoholic steatohepatitis
nonalcoholic steatohepatitis	is a	inflammatory liver disease
nonalcoholic steatohepatitis	can progress to	cirrhosis
alcoholic liver disease	is a	liver disease
alcohol use	is a risk factor for	alcoholic liver disease
alcoholic liver disease	may progress to	cirrhosis
cirrhosis	causes	portal hypertension
cirrhosis	increases risk of	esophageal varices
cirrhosis	increases risk of	hepatocellular carcinoma
cirrhosis	leads to	ascites
ascites	requires	diuretics
ascites	predisposes to	spontaneous bacterial peritonitis
hepatic encephalopathy	occurs in	cirrhosis
hepatic encephalopathy	treated with	lactulose
portal hypertension	causes	splenomegaly
portal hypertension	leads to	variceal formation
hepatitis B infection	is caused by	hepatitis B virus
hepatitis B infection	can be prevented by	vaccination
hepatitis B infection	treated with	antiviral therapy
hepatitis C infection	can be treated with	direct-acting antivirals
hepatitis C infection	can progress to	cirrhosis
chronic hepatitis	is associated with	liver fibrosis
autoimmune hepatitis	is a	autoimmune liver disease
autoimmune hepatitis	treated with	corticosteroids
primary biliary cholangitis	is a	autoimmune liver disease
primary biliary cholangitis	treated with	ursodeoxycholic acid
primary sclerosing cholangitis	is a	cholangiopathy
primary sclerosing cholangitis	associated with	inflammatory bowel disease
hemochromatosis	causes	liver damage
Wilson disease	causes	copper accumulation
drug-induced liver injury	is a	cause of liver dysfunction
drug-induced liver injury	caused by	acetaminophen
acetaminophen	overdose	acute liver failure
acute liver failure	is a	medical emergency
liver transplantation	is a	curative treatment for end-stage liver disease
liver biopsy	is a	diagnostic procedure
elastography	assesses	liver fibrosis
liver stiffness	correlates with	fibrosis stage
bilirubin	is elevated in	cholestasis
alkaline phosphatase	is elevated in	cholestasis
albumin	decreases in	cirrhosis
INR	increases in	cirrhosis
platelets	decrease in	portal hypertension
lipids	are altered in	fatty liver disease
diabetes mellitus	is a risk factor for	nonalcoholic fatty liver disease
metabolic syndrome	is associated with	nonalcoholic fatty liver disease
vaccination	prevents	hepatitis B infection
antiviral therapy	treats	hepatitis B infection
direct-acting antivirals	treat	hepatitis C infection
steroids	treat	autoimmune hepatitis
ursodeoxycholic acid	treats	primary biliary cholangitis
ursodeoxycholic acid	treats	primary sclerosing cholangitis
phlebotomy	treats	hemochromatosis
copper chelation therapy	treats	Wilson disease
withdrawal of offending agent	manages	drug-induced liver injury
lactulose	treats	hepatic encephalopathy
rifaximin	used for	hepatic encephalopathy
hepatitis B vaccine	prevents	hepatitis B infection
HBV DNA levels	monitor	hepatitis B activity
HCV RNA levels	monitor	hepatitis C activity
liver function tests	monitor	liver disease
alpha-fetoprotein	rises in	hepatocellular carcinoma
hepatocellular carcinoma	arises from	cirrhosis
cholangiocarcinoma	arises from	bile ducts
bile duct obstruction	causes	cholestasis
bile acids	accumulate in	cholestasis
spontaneous bacterial peritonitis	occurs in	ascites
hepatorenal syndrome	occurs in	decompensated cirrhosis
end-stage liver disease	requires	liver transplantation
hepatic adenoma	is a	benign liver tumor
hemangioma	is a	benign liver tumor
hepatic cyst	is a	benign liver lesion
portal vein thrombosis	occurs in	cirrhosis
Budd-Chiari syndrome	is a	hepatic vascular disorder
TIPS	reduces	portal hypertension
hepatic venous pressure gradient	estimates	portal hypertension
sarcopenia	is associated with	cirrhosis
infection	risk increases in	cirrhosis
neutrophil dysfunction	occurs in	cirrhosis
dietary modification	used for	NAFLD management
weight loss	improves	NAFLD
exercise	improves	metabolic syndrome
steatosis	is found in	fatty liver
NAFLD	defined by	fat accumulation in liver
cirrhosis	defines	end-stage liver disease
ammonia	contributes to	hepatic encephalopathy
systemic inflammation	aggravates	cirrhosis
renal failure	occurs with	hepatorenal syndrome
autoimmune hepatitis	associated with	other autoimmune diseases
primary biliary cholangitis	progression associated with	cirrhosis
primary sclerosing cholangitis	progression associated with	cholestasis
bile duct cancer	is a	malignant tumor
cholestasis	causes	pruritus
portal hypertension	predisposes to	variceal bleeding
liver transplantation waitlist status	affects	mortality
donor availability	affects	liver transplantation feasibility
post-transplant immunosuppression	modulates	infection risk
